Suzana Bračič (Author), Christoph Schatz (Author), Johannes Haybaeck (Author)

Abstract

The mortality of hepatocellular carcinoma (HCC) is distributed unevenly worldwide. One of the major causes is hepatitis B or hepatitis C virus infection and the development and progression of liver cirrhosis. The carcinogenesis of HCC is among others regulated via the mTOR (mechanistic target of rapamycin) signaling pathway and represents a possible method of targeted treatment. The aim of our article was to address the most recent clinical advances and findings of basic studies on the mTOR signaling pathway and the involved factors. Risk factors play a key role in dysregulation of the signaling pathway, where both mTORCs are upregulated and protein synthesis is altered. eIFs and, to a lesser extent, eEFs play an essential role in this process. Whether the factor will be upregulated or downregulated, among others, depends on hepatitis B/C virus infection. The amount of a particular factor in a patient sample lets us know whether HCC recurrence will occur, what is the likelihood of chemoresistance, and what outcome is predicted for patients with an increased value. Our analysis shows that in addition to mTOR, eIF3, eIF4, and eIF5 play an important role, as they can serve as biomarkers for non- and virus-related HCC.

Keywords

mTOR;virus related HCC;non-virus related HCC;cancer;translation initiation;liver;

Data

Language: English
Year of publishing:
Typology: 1.02 - Review Article
Organization: UM MF - Faculty of Medicine
Publisher: Dovepress
UDC: 616.36-006
COBISS: 83680515 Link will open in a new window
ISSN: 1177-8881
Views: 0
Downloads: 0
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary language: Slovenian
Secondary keywords: Hepatocelularni karcinom;rak;povezava z virusom;začetek prevajanja;jetra;
Type (COBISS): Scientific work
Pages: str. 4359-4369
Issue: ǂVol. ǂ15
Chronology: 2021
DOI: 10.2147/DDDT.S255582
ID: 25325960